EVENT SUMMARY
The AJMC® annual PCOC conference unites leaders in oncology and value-based care, offering valuable insights into the dynamic, rapidly changing oncology care landscape. Our theme, “Innovations in Cancer Care: Tales from the Front Line,” was carried out from our keynote speaker, Matthew Zachary, to the panels from The US Oncology Network, OneOncology, American Oncology Network, and Florida Cancer Specialists & Research Institute (FCS). Providers shared how they bring value to practices and patients. Emily Touloukian, DO, of Coastal Cancer Center, noted how joining OneOncology in 2023 offered protection to her practice during the Change Healthcare cyberattack. In a discussion that took on greater meaning in the weeks after PCOC, FCS’ Chris Elder, PharmD, BCOP, shared how members of his pharmacy team have developed hurricane preparation protocols to prevent loss of expensive cancer drugs. For more coverage of PCOC 2024, see our special recap issue, which will be released in December.

Fertility Preservation Advocacy Challenges

Matthew Zachary said an achievement of the Gen X movement, Stupid Cancer, is to push for adolescents and young adults to preserve their ability to become parents years after cancer treatment ends. However, only 18 states cover fertility preservation.

Expanding Roles for Pharmacists

PCOC’s first all-pharmacy panel offered insights on how much more these professionals could bring to care delivery with full provider status. Automation and AI could eliminate repetitive tasks to allow pharmacists to fill critical gaps amid the oncologist shortage.

Navigating CMS Billing Codes

PCOC isn’t afraid to get into the weeds. Thyme Care’s Lalan Wilfong, MD, led a detailed discussion on how CMS’ new patient navigation codes interface with other billing codes alongside the Enhancing Oncology Model (EOM); other codes include Chronic Care Management and Principal Care Management. Panelists shared how they hoped CMS would do more to allow telehealth to mesh with these codes after the experience in the pandemic.

Inflation Reduction Act Impact

A panel featuring pharma industry insiders illuminated the effects of the Inflation Reduction Act. If drugs are added to the Medicare Fair Price negotiations, sponsors are unlikely to seek indications for small populations going forward, and instead will wait to seek all indications at once.

IRA's Effect on EOM Costs

The IRA will intersect with the EOM for providers, because when patients reach the catastrophic phase, Medicare’s share of total cost of care will shift from 80% to 20% on January 1, 2025, pulling down the average cost of Part D drugs; this will widen disparities in costs with infused drugs.

Precision Medicine and Sequencing

Davey Daniel, MD, chief medical officer for OneOncology, who took part in a fireside chat on precision medicine, said we’ve reached the “tipping point” for next-generation sequencing—where it is the standard of care. He implied we may reach that point for minimal residual disease testing with more real-world evidence.

PCOC 2024 BY THE NUMBERS
The following titles were accurate as of the PCOC 2024 event but may have changed since then.
52
Faculty
36
Institutions Represented Among Faculty
10
Multidisciplinary Panel Discussions
2
Fireside Chats
1
Featured Speaker Session
19
Articles & Videos Produced by AJMC®
Lalan S. Wilfong, MD
Lalan S. Wilfong, MD

Senior Vice President, Value Based Care, Thyme Care

Susan Sabo-Wagner, MSN, RN, OCN, NEA-BC
Susan Sabo-Wagner, MSN, RN, OCN, NEA-BC

Vice President of Clinical Innovation, American Oncology Network

Matthew Zachary
Matthew Zachary

Founder, Stupid Cancer

Judith Alberto, RPh, BCOP, MHA
Judith Alberto, RPh, BCOP, MHA

Director of Clinical Initiatives, Community Oncology Alliance

Grant Andres, BSc, DC, BSN, MSN-RN, CLSSBB, CPHQ
Grant Andres, BSc, DC, BSN, MSN-RN, CLSSBB, CPHQ

Senior Director, Clinical Operations, Arizona Oncology

Edward R. ``Ted`` Arrowsmith, MD, MPH
Edward R. ``Ted`` Arrowsmith, MD, MPH

Executive Vice President of Quality and Clinical Operations, Physician Services, and Therapeutics, Tennessee Oncology

Derek Asay
Derek Asay

Senior Vice President, Government Strategy and Federal Accounts, Lilly USA

Amy J. Barton, MHA
Amy J. Barton, MHA

Regional Director, Managed Care, The US Oncology Network

Nicholas Capote, PharmD, MS, BCSCP
Nicholas Capote, PharmD, MS, BCSCP

Pharmacy Director, Oncology, Infusion, and Investigational Drug Pharmacy Services, UCSF Health

Sophia Humphreys, PharmD, MHA, BCBBS
Sophia Humphreys, PharmD, MHA, BCBBS

Director, System Pharmacy Formulary Management & Clinical Programs, Sutter Health

Sarah Hogue, PharmD
Sarah Hogue, PharmD

Director, Oncology Pharmacy Services, St. Luke's Cancer Institute

Ryan Haumschild, PharmD, MS, MBA, CPEL
Ryan Haumschild, PharmD, MS, MBA, CPEL

Vice President of Ambulatory Pharmacy, Emory Healthcare and the Winship Cancer Institute

Alexandra Hacker
Alexandra Hacker

Director of Quality Programs & Health Outcomes, Williamette Valley Cancer Institute and Research Center

Gustavo Fonseca, MD, FACP
Gustavo Fonseca, MD, FACP

Physician Director of Clinical Research, Florida Cancer Specialists & Research Institute

Mark Fendrick, MD
Mark Fendrick, MD

Director, Center for Value-Based Insurance Design, University of Michigan

Chris Elder, PharmD, BCOP
Chris Elder, PharmD, BCOP

Associate Director of Pharmacy Clinical Services, Florida Cancer Specialists and Research Institute

Chinyere Eigege, PhD, LCSW-S
Chinyere Eigege, PhD, LCSW-S

Manager, Central Social Work Operations, McKesson Corporation

Josh Eaves
Josh Eaves

Chief Development and Strategy Officer, Florida Cancer Specialists & Research Institute

David Eagle, MD
David Eagle, MD

Chair of Legislative Affairs and Patient Advocacy, New York Cancer & Blood Specialists

Stephen “Fred” Divers, MD
Stephen “Fred” Divers, MD

Chief Medical Officer, American Oncology Network

Davey B. Daniel, MD
Davey B. Daniel, MD

Chief Medical Officer, OneOncology

Misty D. Chicchirichi, MSN, RN, CEMC
Misty D. Chicchirichi, MSN, RN, CEMC

Senior Director, Quality Programs, Shenandoah Oncology

Melody Chang, RPh, BCOP, MBA
Melody Chang, RPh, BCOP, MBA

Vice President of Pharmacy Operations, American Oncology Network

Paul Chadwick
Paul Chadwick

Chief Value and Procurement Officer, Florida Cancer Specialists & Research Institute

Sarah Hogue, PharmD
Sarah Hogue, PharmD

Director, Oncology Pharmacy Services, St. Luke's Cancer Institute

Sophia Humphreys, PharmD, MHA, BCBBS
Sophia Humphreys, PharmD, MHA, BCBBS

Director, System Pharmacy Formulary Management & Clinical Programs, Sutter Health

Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA
Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA

Clinical Pharmacy Manager, Division of Hematologic Malignances and Cellular Therapeutics, University of Kansas Cancer Center

Dax Kurbegov, MD, FASCO
Dax Kurbegov, MD, FASCO

Senior Vice President, Sarah Cannon Cancer Network

Brian Koffman, MDCM (retired), DCFP, FCFP, DABFP, MSEd
Brian Koffman, MDCM (retired), DCFP, FCFP, DABFP, MSEd

Clinical Professor (retired), Keck School of Medicine of USC

Sindhuja Kadambi, MD, MS
Sindhuja Kadambi, MD, MS

Assistant Professor, University of Rochester Medical Center

David Jackman, MD
David Jackman, MD

Medical Director, Clinical Pathways and New Business Initiatives, Dana-Farber Cancer Institute

Maen Hussein, MD
Maen Hussein, MD

Medical Oncologist, Florida Cancer Specialists & Research Institute

Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA
Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA

Clinical Pharmacy Manager, Division of Hematologic Malignances and Cellular Therapeutics, University of Kansas Cancer Center

Richard Lewis Martin III, MD, MPH
Richard Lewis Martin III, MD, MPH

Director, Health Equity and Community Engagement, Tennessee Oncology

Kiana Mehring, MBA
Kiana Mehring, MBA

Senior Director of Strategic Partnerships, Managed Care, Florida Cancer Specialists & Research Institute

Alex Morozov, MD, PhD
Alex Morozov, MD, PhD

Chief Medical Officer, Pi Health

Brian P. Mulherin, MD
Brian P. Mulherin, MD

Medical Director, American Oncology Network, Inc

Samyukta ``Sam`` Mullangi, MD, MBA
Samyukta ``Sam`` Mullangi, MD, MBA

Medical Director, Medical Oncologist Thyme Care, Tennessee Oncology

Chris O'Dell
Chris O'Dell

Senior Vice President, Market Solutions, Turquoise Health

Kathy Oubre, MS
Kathy Oubre, MS

Chief Executive Officer, Pontchartrain Cancer Center

Kathryn Paliotta, RN
Kathryn Paliotta, RN

Vice President, Patient Communications, New York Cancer & Blood Specialists

Anne Marie F. Rainey, MSN, RN, CHC, CPHQ
Anne Marie F. Rainey, MSN, RN, CHC, CPHQ

Director of Value-Based Care, American Oncology Network

Alti Rahman, MHA, MBA, CSSBB
Alti Rahman, MHA, MBA, CSSBB

Chief Strategy and Innovation Officer, American Oncology Network

Lisa Raff, PharmD, MSPharm, BCPS, BCOP
Lisa Raff, PharmD, MSPharm, BCPS, BCOP

Vice President of Pharmacy Services, OneOncology

Judi Payne-De Bock, BSN
Judi Payne-De Bock, BSN

Senior Director Clinical Services, US Oncology Network

Barry Russo, MBA
Barry Russo, MBA

Chief Executive Officer, The Center for Cancer and Blood Disorders

BrandiLee Sawyer
BrandiLee Sawyer

Patient Care Coordinator, First Ascent Biomedical

Alyssa Schatz, MSW
Alyssa Schatz, MSW

Vice President, Policy and Advocacy, National Comprehensive Cancer Network

Scott Soefje, PharmD, MBA, BCOP, FCCP, FHOPA
Scott Soefje, PharmD, MBA, BCOP, FCCP, FHOPA

Assistant Professor, Mayo Clinic College of Medicine and Science

Bruce Wilson
Bruce Wilson

Vice President US Oncology Care & Access, AstraZeneca

Dana Weber, MSN, RN
Dana Weber, MSN, RN

Sr. Manager, Transformation & Quality, The US Oncology Network

Emily Touloukian, DO
Emily Touloukian, DO

President and CEO, Coastal Cancer Center

Ann Sweeney, MA, CCMP
Ann Sweeney, MA, CCMP

Senior Director Quality Programs & Process Improvement, Blue Ridge Cancer Care

Samuel Stolpe, PharmD, MPH
Samuel Stolpe, PharmD, MPH

Head of Healthcare Quality Strategy, Johnson & Johnson Innovative Medicine

Stuart Staggs, MSIE
Stuart Staggs, MSIE

Vice President, Transformation & Shared Services, US Oncology Network

Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA
Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA

Clinical Pharmacy Manager, Division of Hematologic Malignances and Cellular Therapeutics, University of Kansas Cancer Center

ATTENDEES REPRESENT LEADING INSTITUTIONS IN VALUE-BASED ONCOLOGY CARE
  • AbbVie
  • American Oncology Network
  • Amgen
  • Arizona Oncology
  • AstraZeneca
  • BeiGene
  • Biolyte
  • Blue Ridge Cancer Care
  • Boehringer Ingelheim Pharmaceuticals
  • Coastal Care Center
  • City of Hope
  • Daiichi Sankyo
  • DGH Consulting/CT Oncology Assoc
  • DRM
  • Eagle Pharmaceuticals
  • Eli Lilly and Company
  • EMD Serono
  • Emory Healthcare and Winship Cancer Institute
  • Employer Direct Healthcare
  • EXPO
  • First Ascent Biomedical
  • Flatiron Health
  • Florida Cancer Specialists and Research Institute
  • Fresenius Kabi
  • G1 Therapeutics
  • Genmab
  • GlaxoSmithKline
  • GSK
  • Healthcare Navigation Solutions
  • Incyte Corporation
  • Janssen
  • Johnson & Johnson
  • Lantheus
  • Leynek Medical
  • Lilly
  • Mayo Clinic
  • McKesson
  • Menarini-Stemline
  • Merck
  • New York Cancer & Blood Specialists
  • Nexus Health LLC
  • Oncentric
  • Oncohealth
  • OneOncology
  • Patient Discovery Solutions, Inc.
  • Pfizer Oncology
  • Pharmacosmos Therapeutics, Inc.
  • PharmaEssentia
  • Pi Health
  • Pontchartrain Cancer Center – Covington
  • Prime Therapeutics| MRx Management
  • Sanofi
  • Shenandoah Oncology
  • Smirta Innovations
  • Springworks Therapeutics
  • Stemline
  • Stupid Cancer
  • Sutter Health
  • Taiho Oncology
  • Takeda Oncology
  • Tennessee Oncology
  • The Center for Cancer and Blood Disorders
  • The US Oncology Network
  • Thyme Care
  • Turquoise Health
  • University of Kansas Cancer Center
  • UCSF Health
  • Vanderbilt University Medical Center
  • Williamette Valley Cancer Institute and Research Center
WHAT YOUR COLLEAGUES ARE READING ON AJMC.COM
Explore the most sought-after PCOC coverage

Progress and Momentum to Improve Patient Access to Quality, Timely Cancer Care

Keeping Up With Evolving Data to Better Cancer Care

Driving Innovation in Cancer Care, Redefining Value, and Improving Patient Access

Redefining Patient-Provider Relationships: Cancer Survivor Matthew Zachary

The Long Arc of Advocacy to Improve the Lives of Patients With Cancer

Access Video Interviews from PCOC
Read the PCOC Recap Issue

This site uses cookies. Find out more about cookies and how you can refuse them.

I Accept